Global Pulmonology Pleuroscopy and Tracheostomy Device Market Strategic Research Report

Scope of the Report

The global Pulmonology Pleuroscopy and Tracheostomy Device market size is predicted to grow from US$ 2,261 million in 2025 to US$ 3,702 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

Interventional pulmonology uses non-surgical, minimally invasive procedures for the diagnosis and treatment of lung cancer, thoracic cancer, tracheal cancer and other diseases related to the respiratory system. It relies on endoscopic techniques, which involve inserting an instrument into the human body to view internal organs and tissues and to conduct additional procedures. Interventional pulmonary medicine is also used to treat related symptoms that may cause discomfort, such as shortness of breath, coughing, and chest pain.

Interventional pulmonology has revolutionized the field of pulmonary (related to the lungs and breathing) medicine by providing the most advanced minimally invasive procedures to diagnose and treat both malignant and non-malignant disorders of the lungs and airways.

Procedures for interventional pulmonology include: Bronchoscopes, Pleuroscopes, Respiratory Endotherapy Devices (Aspiration Needles, Biopsy Forceps, Biopsy brush, Biopsy Needles, pulmonary catheter, balloon dilatation catheter), Airway Stents, Pleural Catheters, Endobronchial Valves, Bronchial Thermoplasty Systems, etc.

The growing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), pneumonia, lung cancer, and other chronic pulmonary conditions, is a major driver of the pulmonology pleuroscopy and tracheostomy device market. Pleuroscopy, a minimally invasive procedure to examine the pleural cavity, and tracheostomy devices, used for airway management, are increasingly vital in the treatment of these respiratory disorders. As the global aging population increases, the demand for these procedures and devices is expected to rise. Additionally, technological advancements in device design, including more efficient pleuroscopy tools and innovative, comfortable tracheostomy tubes, have enhanced the effectiveness and safety of these procedures, encouraging adoption in clinical settings.

The significant challenges in the pulmonology pleuroscopy and tracheostomy device market is the high cost associated with these devices and procedures, which may limit their accessibility, especially in emerging markets. In addition, complications and risks related to tracheostomy, such as infections, accidental dislodgement, and long-term care requirements, can deter widespread adoption. The complexity of the procedures and the need for skilled clinicians can also present barriers to market growth. Furthermore, regulatory hurdles and the need for continuous innovation in device design to improve patient outcomes and minimize risks can delay product development and increase costs for manufacturers.

Americas is the largest consumption place, with a consumption market share nearly 37% in 2022. Following Americas, APAC is the second largest consumption place with the consumption market share of 32%.

Global main Pulmonology, Pleuroscopy and Tracheostomy Device players cover Boston Scientific, Olympus, Medtronic, Ambu A/S, Pentax (HOYA), Micro Tech, etc. In terms of revenue, the global largest five manufacturers occupy a share nearly 68% in 2023.

This report presents a comprehensive overview of the global Pulmonology Pleuroscopy and Tracheostomy Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Bronchoscope
• Pleuroscopy
• Respiratory Endotherapy Devices
• IP Therapeutic Device
• Tracheostomy Tube
• Others

Segment by Application

• Hospital and Clinic
• Ambulatory Surgical Centers
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pulmonology Pleuroscopy and Tracheostomy Device market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital and Clinic, Ambulatory Surgical Centers, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact